2015
DOI: 10.1002/14651858.cd011580
|View full text |Cite
|
Sign up to set email alerts
|

Radiotherapy for advanced-stage aggressive non-Hodgkin lymphoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…Ernie et al reported that radiotherapy has a modest benefit in terms of overall survival, event-free survival, and local control for patients with advanced-stage aggressive NHL in comparison with an observation policy. 5 In our case, periodic MRI evaluations revealed the remaining gadolinium enhanced lesion, which meant that the existence of a residual viable tumor could not be completely ruled out. Rahmouni et al previously reported the enhancement of residual gadolinium after treatment to be associated with a local relapse based on their experience of performing periodic MRI evaluations in 21 patients with mediastinal lymphoma.…”
mentioning
confidence: 66%
“…Ernie et al reported that radiotherapy has a modest benefit in terms of overall survival, event-free survival, and local control for patients with advanced-stage aggressive NHL in comparison with an observation policy. 5 In our case, periodic MRI evaluations revealed the remaining gadolinium enhanced lesion, which meant that the existence of a residual viable tumor could not be completely ruled out. Rahmouni et al previously reported the enhancement of residual gadolinium after treatment to be associated with a local relapse based on their experience of performing periodic MRI evaluations in 21 patients with mediastinal lymphoma.…”
mentioning
confidence: 66%